MedicationsSexual healthSkin health

What to know about gonorrhea and its treatments

Learn about the sexually transmitted infection and why medication therapies have changed over time.

Jan, 20264 min read
LearnDermatologyGonorrheaWhat to know about gonorrhea and its treatments
  • Gonorrhea symptoms and complications
  • Antibiotic resistance and gonorrhea treatment
  • Screening for gonorrhea infection

Gonorrhea is a sexually transmitted bacterial infection that can affect both men and women. Each year, more than 500,000 adults in the United States are diagnosed, according to the Centers for Disease Control and Prevention (CDC). While gonorrhea is most common in young people aged 15 to 24, anyone who has unprotected sex is at risk for being infected.

Though it’s long been considered curable with medication, gonorrhea has become harder to treat in recent years. That’s because the bacteria that causes the infection has grown resistant to many of the drugs used in the past. But in 2025, for the first time in decades, the U.S. Food & Drug Administration (FDA) approved two new oral medications for treatment, zoliflodacin and gepotidacin.

Gonorrhea symptoms and complications

Gonorrhea is caused by Neisseria gonorrhoeae (N. gonorrhoeae), a type of bacteria. It can infect the:

  • Mouth and throat
  • Eyes
  • Rectum, the last part of your digestive system
  • Urethra, tube that carries urine out of the body
  • The female reproductive system, including the uterus (womb) and vagina

Gonorrhea often has no noticeable symptoms, especially for women. But it can cause pain or burning during urination and discharge from the penis or vagina.

Left untreated, gonorrhea can become more serious. The infection can lead to pain in the pelvis and abdomen, pregnancy complications, and infertility issues in both men and women. It can also cause pelvic inflammatory disease (PID) in women. PID is a serious infection of the upper genital tract involving the uterus, fallopian tubes, and ovaries. In some cases, a pregnant person may pass gonorrhea to their baby during birth. Gonorrhea can also increase the risk of acquiring HIV.

Antibiotic resistance and gonorrhea treatment

Antibiotics are drugs used to treat bacterial infections. Over time, N. gonorrhoeae has become increasingly resistant to a variety of antibiotics. That means the drugs no longer work as well as they used to. Eventually, they may not work at all.

The resistance is caused by many factors, including genetic mutations within N. gonorrhoeae and overuse of antibiotics in general. When antibiotics are used unnecessarily on a large scale, it helps stronger bacteria to survive and multiply, leading to more powerful infections that no longer respond to treatments.

The Centers for Disease Control and Prevention (CDC) used to recommend treating gonorrhea with the antibiotics azithromycin and ceftriaxone. Due in part to increasing resistance, the CDC updated guidelines in 2020 to recommend that only a single injection of ceftriaxone be used. Ceftriaxone remains a first-line treatment.

In 2025, the FDA’s approval of zoliflodacin and gepotidacin gave healthcare providers (HCPs) additional treatment options. Both antibiotics treat uncomplicated urogenital gonorrhea, which means the infection hasn’t spread to the blood or other body parts.

  • Zoliflodacin is a single-dose treatment, given as granules that dissolve in water. It’s meant for people ages 12 and older who weigh 77 pounds or more.
  • Gepotidacin is given in two doses of four tablets each about 12 hours apart. It’s meant for people who are 17 and older who weigh at least 99 pounds.

Whatever medication a person receives, if symptoms continue for more than a few days afterward, a follow-up test should be given to ensure effective treatment. People with gonorrhea should also be retested three months after treatment, regardless of whether they think their sexual partners were successfully treated, too.

Screening for gonorrhea infection

A screening is a test that looks for signs of a disease before symptoms appear. It’s one of the best ways to detect an infection and prevent it from growing worse or spreading. Some people should be screened for gonorrhea once a year. They include the following, according to the CDC:

  • All sexually active women ages 24 years or younger
  • Women 25 years or older who are at increased risk for infection
  • Men who have sex with men

These factors may raise infection risk:

  • If you have more than one sex partner
  • If your partner is having sex with other people
  • If you’re not in a monogamous relationship and you don’t use condoms consistently
  • If you have had a sexually transmitted infection in the past or currently have one

Men who have sex with men and have multiple or anonymous partners should be screened more than one time a year. Talk with your HCP about whether and how often it makes sense for you to be screened.

If you develop symptoms of gonorrhea, always be sure to check in with an HCP. The sooner you can get effective treatment, the better your chances of eliminating the infection.

Sources: Centers for Disease Control and Prevention. STI Statistics. September 24 + 17
  1. Centers for Disease Control and Prevention. STI Statistics. September 24, 2025.
  2. Centers for Disease Control and Prevention. About Gonorrhea. January 31, 2025.
  3. Mayo Clinic. Gonorrhea: Symptoms and Causes. September 13, 2024.
  4. Office on Women’s Health. Gonorrhea. October 24, 2025.
  5. World Health Organization. Multi Drug Resistant Gonorrhoea. October 22, 2025.
  6. CIDRAP. WHO Warns of Rising, Worrisome Levels of Drug Resistant Gonorrhea. November 19, 2025.
  7. Centers for Disease Control and Prevention. Drug Resistant Gonorrhea. February 15, 2024.
  8. KidsHealth. The Danger of Antibiotic Overuse. April 2023.
  9. Kirkcaldy RD, Harvey A, et al. Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance — The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014. MMWR Surveill Summ 2016;65(No. SS-7):1–19.
  10. Centers for Disease Control and Prevention. Update to CDC's Treatment Guidelines for Gonococcal Infection, 2020. December 18, 2020.
  11. U.S. Food and Drug Administration. FDA Approves Two Oral Therapies to Treat Gonorrhea. December 12, 2025.
  12. Jacqueline Howard. FDA approves first new antibiotics to treat gonorrhea in decades, with hope to combat drug resistance. CNN.com. December 12, 2025.
  13. GSK. Blujepa Prescribing Information. Accessed January 13, 2026.
  14. Wisconsin Department of Health Services. Antibiotic-Resistant Gonorrhea. June 17, 2025.
  15. Centers for Disease Control and Prevention. Gonococcal Infections Among Adolescents and Adults. September 21, 2022.
  16. World Health Organization. Gonorrhoea Antimicrobial Resistance: Results and Guidance for Vaccine Development. November 22, 2021.
  17. U.S. Preventive Services Task Force. Chlamydia and Gonorrhea Screening. September 14, 2021.
  18. Centers for Disease Control and Prevention. STI Testing. January 31, 2025.
Written byMargaret Bristol.
Medically reviewed byMegan Burke, MD.January, 2026
Updated onJanuary, 2026
ask-md
AskMD
Questions about Medications?
Written byMargaret Bristol.
Medically reviewed byMegan Burke, MD.January, 2026
Updated onJanuary, 2026
  • Gonorrhea symptoms and complications
  • Antibiotic resistance and gonorrhea treatment
  • Screening for gonorrhea infection
ask-md
AskMD
Curious about Medications?
Sources: Centers for Disease Control and Prevention. STI Statistics. September 24 + 17
  1. Centers for Disease Control and Prevention. STI Statistics. September 24, 2025.
  2. Centers for Disease Control and Prevention. About Gonorrhea. January 31, 2025.
  3. Mayo Clinic. Gonorrhea: Symptoms and Causes. September 13, 2024.
  4. Office on Women’s Health. Gonorrhea. October 24, 2025.
  5. World Health Organization. Multi Drug Resistant Gonorrhoea. October 22, 2025.
  6. CIDRAP. WHO Warns of Rising, Worrisome Levels of Drug Resistant Gonorrhea. November 19, 2025.
  7. Centers for Disease Control and Prevention. Drug Resistant Gonorrhea. February 15, 2024.
  8. KidsHealth. The Danger of Antibiotic Overuse. April 2023.
  9. Kirkcaldy RD, Harvey A, et al. Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance — The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014. MMWR Surveill Summ 2016;65(No. SS-7):1–19.
  10. Centers for Disease Control and Prevention. Update to CDC's Treatment Guidelines for Gonococcal Infection, 2020. December 18, 2020.
  11. U.S. Food and Drug Administration. FDA Approves Two Oral Therapies to Treat Gonorrhea. December 12, 2025.
  12. Jacqueline Howard. FDA approves first new antibiotics to treat gonorrhea in decades, with hope to combat drug resistance. CNN.com. December 12, 2025.
  13. GSK. Blujepa Prescribing Information. Accessed January 13, 2026.
  14. Wisconsin Department of Health Services. Antibiotic-Resistant Gonorrhea. June 17, 2025.
  15. Centers for Disease Control and Prevention. Gonococcal Infections Among Adolescents and Adults. September 21, 2022.
  16. World Health Organization. Gonorrhoea Antimicrobial Resistance: Results and Guidance for Vaccine Development. November 22, 2021.
  17. U.S. Preventive Services Task Force. Chlamydia and Gonorrhea Screening. September 14, 2021.
  18. Centers for Disease Control and Prevention. STI Testing. January 31, 2025.

Recommended for you

What to know about preventing sexually transmitted infections
Article
Infectious diseases
Surprising ways STIs affect the sexes differently
Slideshow
Urology
What you need to know about drug-resistant UTIs
Article
Infectious diseases
Why some infections are getting harder to treat
Article
Infectious diseases
What to know about mpox
Video
AskMDHow can I be more consistent?
AskMd LogoAskMd Logo
Privacy policyConsumer health data privacyTerms of use
Cookie policyYour privacy choices

© 2026 Sharecare, Inc.